Ventas (VTR)CFO sold ~$267K

~$267K

Approx. value · 3,900 sh @ $68.45

168K

Holds after · shares reported

Traded

Jul 31, 2025

Filed

Aug 1, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jul 14, 2025Insider · 2 peopleInsiders: 2 sales (~$12.0M)
2. Jul 15, 2025InsiderCEO sold ~$19K of VTR shares in the open market
3. Jul 16, 2025InsiderCEO sold ~$80K of VTR shares in the open market
4. Jul 18, 2025Insider · 2 peopleInsiders: 2 sales (~$559K)
5. Jul 21, 2025InsiderCFO sold ~$1.95M of VTR shares in the open market
6. Jul 31, 2025 · this disclosureInsiderCFO sold ~$267K of VTR shares in the open market

What came next

1. Aug 1, 2025InsiderCEO sold ~$696K of VTR shares in the open market
2. Aug 4, 2025InsiderCFO sold ~$2.03M of VTR shares in the open market
3. Sep 2, 2025InsiderCEO sold ~$700K of VTR shares in the open market
4. Sep 15, 2025InsiderCEO sold ~$28K of VTR shares in the open market
5. Sep 30, 2025InsiderCEO sold ~$143K of VTR shares in the open market
6. Oct 1, 2025Insider · 2 peopleInsiders: 2 sales (~$904K)
7. Oct 20, 2025Insider · 1 personInsiders: 2 sales (~$15.7M)
8. Oct 29, 2025Company filing · Form 8-K · ResultsReported its results
9. Oct 30, 2025Insider · 1 personInsiders: 4 sales (~$23.6M)
10. Nov 3, 2025Insider · 1 personInsiders: 2 sales (~$1.5M)
11. Nov 4, 2025Insider · 2 peopleInsiders: 2 sales (~$1.2M)
12. Nov 5, 2025Insider · 2 peopleInsiders: 2 sales (~$1.5M)
13. Nov 6, 2025Insider · 2 peopleInsiders: 2 sales (~$32K)
14. Nov 7, 2025InsiderCEO sold ~$3K of VTR shares in the open market
15. Nov 12, 2025InsiderCFO sold ~$2.58M of VTR shares in the open market
16. Nov 14, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 17, 2025, Ventas, Inc. (the “Company”) announced that Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, Inc., is expected to retire effective as of May 1, 2026 (the “Effective Date”).”
17. Nov 17, 2025InsiderCEO sold ~$3.26M of VTR shares in the open market
18. Nov 18, 2025InsiderCEO sold ~$222K of VTR shares in the open market
19. Nov 19, 2025InsiderCEO sold ~$179K of VTR shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Ventas

For Ventas, OQRO holds 1 Congress trade report and 16 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VTR page.

Other recent filings by Robert F Probst, EVP and CFO

• SEC Form 4 at Ventas (VTR)Jan 6, 2026
• SEC Form 4 at Ventas (VTR)Nov 14, 2025
• SEC Form 4 at Ventas (VTR)Aug 6, 2025
• SEC Form 4 at Ventas (VTR)Jul 23, 2025
• SEC Form 4 at Ventas (VTR)Jul 18, 2025

The full history of Robert F Probst, EVP and CFO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Ventas

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its VTR page.